Acquisition of resistant microorganisms and infections in HIV-infected patients admitted to the ICU

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 4, 2014, Pages 611-620

  Cobos Trigueros, N ^a   Rinaudo, M ^a   Sole M ^a   Castro, P ^a   Pumarol, J ^a   Hernandez C ^a   Fernandez S ^a   Nicolas J M ^a   Mallolas, J ^a   Vila, J ^a   Morata, L ^a   Gatell, J M ^a   Soriano, A ^a   Mensa, J ^a   Martinez J A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBAMAZEPINE; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; FLUCONAZOLE; HYDROCORTISONE; LEVOFLOXACIN; LINEZOLID; PIPERACILLIN; TAZOBACTAM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG EXPOSURE; ENDOTRACHEAL INTUBATION; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; MIDDLE AGED; MORTALITY; NONHUMAN; NOSE SMEAR; OBSERVATIONAL STUDY; PARENTERAL NUTRITION; PHYSICIAN; POTENTIALLY RESISTANT MICROORGANISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM; STAPHYLOCOCCUS EPIDERMIDIS; THROAT CULTURE; URINARY CATHETER; AGED; CROSS INFECTION; DRUG RESISTANCE; MICROBIOLOGY; STATISTICAL MODEL;

ADULT; AGED; CROSS INFECTION; DRUG RESISTANCE; FEMALE; HIV INFECTIONS; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84897057611     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1995-5     Document Type: Article

References (45)

1. Akgün KM, Pisani M, Crothers K (2011) The changing epidemiology of HIV-infected patients in the intensive care unit. J Intensive Care Med 26:151-164
2. Castro Rebollo P, Nicolás JM, Gatell JM (2007) HIV in the intensive care unit. In: Rello J, Kollef MH, Díaz E, Rodríguez A (eds) Infectious diseases in critical care, 2nd edn. Springer-Verlag, Berlin Heidelberg New York, pp 51-62
3. Huang L, Quartin A, Jones D et al (2006) Intensive care of patients with HIV infection. N Engl J Med 355:173-181
4. Crothers K, Huang L, Goulet JL et al (2011) HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 183:388-395
5. Chiang H-H, Hung C-C, Lee C-M et al (2011) Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care 15:R202
6. Casalino E, Wolff M, Ravaud P et al (2004) Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 18:1429-1433 (Pubitemid 38925135)
7. Zolopa A, Andersen J, Powderly W et al (2009) Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 4:e5575
8. Nguyen MH, Kauffman CA, Goodman RP et al (1999) Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 130:221-225 (Pubitemid 29078783)
9. Padoveze MC, de Jesus Pedro R, Blum-Menezes D et al (2008) Staphylococcus aureus nasal colonization in HIV outpatients: persistent or transient? Am J Infect Control 36:187-191 (Pubitemid 351417669)
10. American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388-416
11. Clinical and Laboratory Standards Institute (CLSI) (2009) Performance standards for antimicrobial susceptibility testing; Nineteenth informational supplement. CLSI document M100-S19. CLSI, Wayne
12. Martínez JA, Nicolás JM, Marco F et al (2006) Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med 34:329-336 (Pubitemid 43145609)
13. Knaus WA, Draper EA, Wagner DP et al (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829 (Pubitemid 15250137)
14. Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710
15. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents, Office of AIDS Research Advisory Council. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, 2007. Available online at: http://www.aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL.pdf
16. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256 (Pubitemid 36444440)
17. Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1-45
18. Ruiz M, Torres A, Ewig S et al (2000) Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 162:119-125 (Pubitemid 30469808)
19. Thomas CF Jr, Limper AH (2004) Pneumocystis pneumonia. N Engl J Med 350:2487-2498
20. Garner JS, Jarvis WR, Emori TG et al (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128-140
21. Centers for Disease Control and Prevention (CDC) (2007) HIV/AIDS surveillance report, 2005. Vol. 17. Rev ed. CDC, Atlanta, pp 16-1
22. Mbulaiteye SM, Biggar RJ, Goedert JJ et al (2003) Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32:527-533 (Pubitemid 36423125)
23. Petroll AE, Hare CB, Pinkerton SD (2008) The essentials of HIV: a review for nurses. J Infus Nurs 31:228-235
24. Puoti M, Spinetti A, Ghezzi A et al (2000)Mortality for liver disease in patients with HIVinfection: a cohort study. J Acquir ImmuneDefic Syndr 24:211-217
25. Schein RM, Fischl MA, Pitchenik AE et al (1986) ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med 14:1026-1027 (Pubitemid 17223758)
26. Adlakha A, Pavlou M, Walker DA et al (2011) Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy. Int J STD AIDS 22:498-504
27. Coquet I, Pavie J, Palmer P et al (2010) Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care 14:R107
28. Japiassú AM, Amâncio RT, Mesquita EC et al (2010) Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care 14:R152
29. Schwaber MJ, Cosgrove SE, Gold HS et al (2004) Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens. Emerg Infect Dis 10:94-99 (Pubitemid 38040699)
30. Martínez JA, Delgado E, Martí S et al (2009) Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients. Intensive Care Med 35:439-447
31. Petrosillo N, Viale P, Nicastri E et al (2002) Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin Infect Dis 34:677-685 (Pubitemid 34165332)
32. Ortega M, Almela M, Soriano A et al (2008) Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality. Eur J Clin Microbiol Infect Dis 27:969-976
33. Meynard JL, Barbut F, Guiguet M et al (1999) Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J Infect 38:176-181 (Pubitemid 29317387)
34. Vidal F, Mensa J, Martínez JA et al (1999) Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 18:473-477 (Pubitemid 29531186)
35. Soufir L, Timsit JF, Mahe C et al (1999) Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 20:396-401
36. Peres-Bota D, Rodriguez H, Dimopoulos G et al (2003) Are infections due to resistant pathogens associated with a worse outcome in critically ill patients? J Infect 47:307-316 (Pubitemid 37322050)
37. Shorr AF (2009) Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med 37:1463-1469
38. Timsit JF, Zahar JR, Chevret S (2011) Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care 17:464-471
39. Bekaert M, Timsit JF, Vansteelandt S et al (2011) Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 184:1133-1139
40. Agrafiotis M, Siempos II, Ntaidou TK et al (2011) Attributable mortality of ventilator-associated pneumonia: a meta-analysis. Int J Tuberc Lung Dis 15:1154-1163
41. Wilcox MH, Tack KJ, Bouza E et al (2009) Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. Clin Infect Dis 48:203-212
42. Sterzik H, Soriano A, Mohamad AM et al (2011) Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin. Scand J Infect Dis 43:765-770
43. Dickson SJ, Batson S, Copas AJ et al (2007) Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax 62:964-968 (Pubitemid 350084495)
44. Alves C, Nicolás JM, Miró JM et al (2001) Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur Respir J 17:87-93 (Pubitemid 32600561)
45. Khouli H, Afrasiabi A, Shibli M et al (2005) Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med 20:327-333